EPIDEMIOLOGICAL ANALYSIS OF MALIGNANT NEOPLASMS OF THE GENITOURINARY SYSTEM AND FEATURES OF PROVIDING MEDICAL CARE TO THE POPULATION IN THE "ONCOLOGY" PROFILE IN THE NORTH-WEST OF THE RUSSIAN FEDERATION (ARKHANGELSK REGION)

Relevance. At the moment, there is an increase in the incidence of malignant neoplasms in the Russian Federation. The Arkhangelsk region is no exception in this case. A fairly significant share of all malignant diseases is occupied by neoplasms of the genitourinary system, which are sometimes difficult to diagnose and eliminate in time. The aim of the work is to identify of the features of the epidemiological situation of morbidity and mortality of the population of the Arkhangelsk region with malignant neoplasms of the genitourinary system, as well as the effectiveness of the organization of the processes of medical care, prevention and early detection of this pathology. Materials and methods. Statistical data (Federal State Statistics Service, Unified Interdepartmental Information and Statistical System, Cancer Register) linked to the incidence of cancer of the genitourinary system in residents of the Arkhangelsk region were used. A comparative analysis was carried out with those on average in the Russian Federation. The results of the study. Throughout the entire study period (from 2011 to 2019, with the exception of 2020), there was an increase in the detection of oncological pathology of the genitourinary system in the population of the Arkhangelsk region. The decline in 2020 is closely related to the spread of COVID-19 and limiting measures. The average mortality rates in the Arkhangelsk region from malignant neoplasms of the genitourinary system from 2011 to 2021 practically did not differ from the average Russian. Since 2016, there has been a slight increase in the indicator of early diagnosis of oncological diseases of the genitourinary system in the region. It reflects the effectiveness of the measures taken to fight cancer, in particular, the introduction of the Federal program "Fight against oncological diseases". The conclusion is made about the need for further implementation of this program, its continuous improvement and exchange of experience with other regions.